Repare Therapeutics logo

Repare Therapeutics Share Price (NASDAQ: RPTX)

$1.65

-0.01

(-0.6%)

Last updated on

Check the interactive Repare Therapeutics Stock chart to analyse performance

Repare Therapeutics stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$1.65
    Today's High:$1.67

    Day's Volatility :1.2%

  • 52 Weeks Low:$0.89
    52 Weeks High:$4.07

    52 Weeks Volatility :78.13%

Repare Therapeutics Stock Returns

PeriodRepare Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
20.44%
3.6%
0.0%
6 Months
42.24%
-7.7%
0.0%
1 Year
-41.28%
-12.6%
0.0%
3 Years
-86.85%
9.5%
-4.7%

Repare Therapeutics Inc Key Stats

Check Repare Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$1.66
Open
$1.65
Today's High
$1.67
Today's Low
$1.65
Market Capitalization
$71.3M
Today's Volume
$48.9K
52 Week High
$4.0695
52 Week Low
$0.89
Revenue TTM
$250.0K
EBITDA
$-110.5M
Earnings Per Share (EPS)
$-2.58
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-69.96%

Stock Returns calculator for Repare Therapeutics Stock including INR - Dollar returns

The Repare Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Repare Therapeutics investment value today

Current value as on today

₹61,985

Returns

₹38,015

(-38.01%)

Returns from Repare Therapeutics Stock

₹43,299 (-43.3%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Repare Therapeutics Stock

-70%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Repare Therapeutics Stock from India on INDmoney has decreased by -70% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Repare Therapeutics Inc

  • Name

    Holdings %

  • Bvf Inc

    24.05%

  • Blue Owl Capital Holdings LP

    8.02%

  • Orbimed Advisors, LLC

    7.73%

  • Versant Venture Management LLC

    6.16%

  • Redmile Group, LLC

    3.69%

  • Aquilo Capital Management, LLC

    3.01%

Analyst Recommendation on Repare Therapeutics Stock

Rating
Trend

Buy

    84%Buy

    15%Hold

    0%Sell

Based on 13 Wall street analysts offering stock ratings for Repare Therapeutics(by analysts ranked 0 to 5 stars)

Repare Therapeutics Share Price Target

What analysts predicted

Upside of 203.03%

Target:

$5.00

Current:

$1.65

Repare Therapeutics share price target is $5.00, a slight Upside of 203.03% compared to current price of $1.65 as per analysts' prediction.

Repare Therapeutics Stock Insights

  • Price Movement

    In the last 3 years, RPTX stock has moved down by -85.7%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, -53.47M → 250.0K (in $), with an average increase of 21490.8% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -30.04M → -16.74M (in $), with an average increase of 79.4% per quarter
  • RPTX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 113.2%
  • RPTX vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 198.3%
  • Price to Sales

    ForRPTX every $1 of sales, investors are willing to pay $275.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.

Repare Therapeutics Technicals Summary

Sell

Neutral

Buy

Repare Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Repare Therapeutics Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Repare Therapeutics Inc logo
10.0%
42.24%
-41.28%
-86.85%
-93.44%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Repare Therapeutics Inc

Repare Therapeutics Inc., a clinical-stage precision oncology company, engages in the discovery and development of therapeutics in Switzerland and the United States. The company uses its proprietary, genome-wide and CRISPR-enabled SNIPRx platform to discover and develop cancer therapies that treat cancers due to mechanisms of genomic instability, including DNA damage repair. It also develops camonsertib (RP-3500), a potent and selective oral small molecule inhibitor of Ataxia-Telangiectasia and Rad3-related protein kinase that is in Phase 1/2 clinical trial for the treatment of solid tumors; and lunresertib (RP-6306), a selective and potent oral small molecule inhibitor of Protein Kinase Membrane-associated tyrosine-and threonine-specific cdc-2 inhibitory kinase that is in Phase 1/2 clinical trial. In addition, the company is developing RP-1664, an oral PLK4 inhibitor in Phase 1 clinical trial to harness the synthetic lethal relationship with TRIM37 amplification or overexpression in solid tumors; and RP-3467, an inhibitor of adenosinetriphosphatase activity on the helicase domain of DNA polymerase theta that is in Phase 1 clinical trial. The company has strategic collaborations with Hoffmann-La Roche Inc., F. HoffmannLa Roche Ltd, Debiopharm International S.A., Bristol-Myers Squibb Company, Ono Pharmaceutical Company Ltd., and New York University. Repare Therapeutics Inc. was incorporated in 2016 and is headquartered in Montreal, Canada.
Organization
Repare Therapeutics
Employees
129
CEO
Mr. Steve Forte CPA
Industry
Health Technology

Key Management of Repare Therapeutics Inc

NameTitle
Dr. Michael Zinda Ph.D.
Executive VP & Chief Scientific Officer
Mr. Steve Forte CPA
President, CFO, CEO & Director
Dr. Daniel Durocher Ph.D.
Co-Founder
Dr. Frank Sicheri Ph.D.
Co-Founder
Dr. Agnel Sfeir Ph.D.
Co-Founder
Ms. Sandra Alves
Senior VP & Chief Accounting Officer
Mr. Daniel Belanger
Executive Vice President of Human Resources
Dr. Joseph P. O'Connell M.D.
Executive Vice President of Clinical Development and Medical Affairs

Important FAQs about investing in RPTX Stock from India :

What is Repare Therapeutics share price today?

Repare Therapeutics share price today is $1.65 as on at the close of the market. Repare Therapeutics share today touched a day high of $1.67 and a low of $1.65.

What is the 52 week high and 52 week low for Repare Therapeutics share?

Repare Therapeutics share touched a 52 week high of $4.07 and a 52 week low of $0.89. Repare Therapeutics stock price today i.e. is closed at $1.65, lower by 59.45% versus the 52 week high.

How to invest in Repare Therapeutics Stock (RPTX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Repare Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Repare Therapeutics Shares that will get you 0.9091 shares as per Repare Therapeutics share price of $1.65 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Repare Therapeutics Stock (RPTX) from India?

Indian investors can start investing in Repare Therapeutics (RPTX) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Repare Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Repare Therapeutics share’s latest price of $1.65 as on August 30, 2025 at 1:29 am IST, you will get 6.0606 shares of Repare Therapeutics. Learn more about fractional shares .

What are the returns that Repare Therapeutics has given to Indian investors in the last 5 years?

Repare Therapeutics stock has given -93.44% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?